Catalyst Wire Dossier Catalyst Wire Dossier

TMC278 (rilpivirine)

rilpivirine · Janssen Pharmaceuticals
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TMC278 (rilpivirine), covering 2010-04-28 to 2011-06-09. Get the full timeline:

Most recent: Clinical Trial Update: TMC278-TiDP38-C145: A Bioavailability Study in Healthy Adult Volunteers to Evaluate 3 Pediatric Formulations of TMC278 (a Solution, a Suspension, and Granules) Compared to an Adult Tablet Formulation [Phase 1]

See pricing